INIT Versus IASTM In Patients With Chronic PF

NCT06493487 | Not Yet Recruiting DMC

• 1 other identifier: INIT versus IASTM in PF
• Study Type: interventional
• Target: 54
• Locations: 0 countries
• Sites: N/A

Brief Summary

1. 1.To investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on general pain intensity in patient with chronic plantar fasciitis.
2. 2.To investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on pain intensity at initial morning step in patient with chronic plantar fasciitis.
3. 3.To investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on pain pressure threshold in patient with chronic plantar fasciitis.
4. 4.To investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on active dorsiflexion ROM in patient with chronic plantar fasciitis.
5. 5.To investigate integrated neuromuscular inhibition versus Instrument assisted soft tissue mobilization on functional disability in patient chronic plantar fasciitis.

Conditions

Planter Fasciitis

Keywords

planter fasciitis; integrated neuromuscular inhibition technique (INIT); Instrument-Assisted Soft Tissue Mobilization (IASTM)

Outcome Measures

Primary Outcomes (1)

• general pain intensity

  general pain intensity at planter aspect of foot will be measured by Visual analog scale (VAS): a horizontal line, 100 mm in length, anchored by word descriptors at each end (0 means no pain to 10 means worth pain). The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks.

  change of general pain intensity through 4 weeks

Secondary Outcomes (1)

• pain intensity in morning initial step

  change of pain intensity in morning initial step through 4 weeks.

Other Outcomes (3)

• Disability function of ankle joint

  change of disability function of ankle joint through 4 weeks

• pain pressure threshold

  change of pain pressure thershold through 4 weeks

• active ankle dorsiflexion range of motion

  change of active ankle dorsiflexion range of motion through 4 weeks

Study Arms (3)

integrated neuromuscular inhibition technique

EXPERIMENTAL

integrated neuromuscular inhibition in addition to conventional treatment

Other: integrated neuromuscular inhibition technique

instrument assisted soft tissue mobilization

EXPERIMENTAL

instrument assisted soft tissue mobilization technique (IASTM) in addition to conventional treatment

Other: instrument assissted soft tissue mobilization

conventional treatment

PLACEBO COMPARATOR

(home education program, therapeutic ultrasound, plantar fascia stretching, intrinsic muscle strengthening of foot, Self stretching of calf muscle using a towel and Ice Massage using frozen bottle).

Other: convential treatment

Interventions

integrated neuromuscular inhibition technique OTHER

integrated neuromuscular inhibition technique for gastrocniemus muscle

integrated neuromuscular inhibition technique

instrument assissted soft tissue mobilization OTHER

instrument assissted soft tissue mobilization for calf muscle

instrument assisted soft tissue mobilization

convential treatment OTHER

convential treatment (home education program, therapeutic ultrasound, plantar fascia stretching, intrinsic muscle strengthening of foot, Self stretching of calf muscle using a towel and Ice Massage using frozen bottle).

conventional treatment

Eligibility Criteria

• Age: 40 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Patient with history of plantar fasciitis more than three months ago.
• Plantar heel pain with first few steps upon walking in the morning and after prolonged rest.
• Patient\'s Age between 40-60 years old.
• Patient\'s Body mass index (BMI 18 to 29.9kg/m2).

You may not qualify if:

• Patients with any prior surgery to distal tibia, fibula, ankle joint or rear foot region.
• Presence of any red flags i.e., tumor, fracture, and heterotrophic ossification and had acute inflammatory condition at ankle-foot region were excluded from the study.
• Deformity of foot and ankle complex and subjects with referred pain due to sciatica and other neurological disorder.

Sponsors & Collaborators

• Cairo University: lead

Study Officials

• magda zahran, Ass.Prof

  faculty of physical therapy

  STUDY DIRECTOR

• Fatma Amin, Professor

  faculty of physical therapy

  STUDY DIRECTOR

• mohammed kaddah, professor

  Cairo University

  STUDY DIRECTOR

Central Study Contacts

esraa khairy afify esmail, B.Sc

CONTACT

+2(02)01013982552; ekhairy851@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, CARE PROVIDER
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 29, 2024
• First Posted: July 10, 2024
• Study Start: July 1, 2024
• Primary Completion: August 1, 2024
• Study Completion: September 1, 2024
• Last Updated: July 10, 2024

Record last verified: 2024-06